Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Nobels, Frank ^a   Debacker, Noëmi ^b   Brotons, Carlos ^c   Elisaf, Moses ^d   Hermans, Michel P ^e   Michel, Georges ^f   Muls, Erik ^g  

^a OLV HOSPITAL   (Belgium)

^b Corilus ^*  (Belgium)

^c BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^d UNIVERSITY OF IOANNINA   (Greece)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT; TRIACYLGLYCEROL BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; METHODOLOGY; MULTICENTER STUDY; STANDARD;

ADULT; BENCHMARKING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; QUALITY OF HEALTH CARE;

EID: 80053173236     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-82     Document Type: Article

References (41)

1. IDF Diabetes Atlas. 4., http://www.diabetesatlas.org/
2. Jönsson B, . CODE-2 Advisory Board Revealing the cost of Type II diabetes in Europe. Diabetologia 2002, 45:S5-S12. 10.1007/s00125-002-0858-x, 12136405, CODE-2 Advisory Board.
3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
4. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, . Cholesterol Treatment Trialists' Collaborators Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 2005, 366:1267-1278. Cholesterol Treatment Trialists' Collaborators.
5. Fuller J, Stevens LK, Chaturvedi N, Holloway JF. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus. Cochrane Database Syst Rev 2000, 2:CD002188.
6. Institute of Medicine Crossing the quality chasm: a new health system for the 21st century 2001, Washington, DC: National Academy Press, Institute of Medicine.
7. Davidson M. How our current medical care system fails people with diabetes. Lack of timely, appropriate clinical decisions. Diabetes Care 2009, 32:370-372. 2628710, 19171736.
8. Weingarten S, Henning J, Badamgarav E, Knight K, Hasselblad V, Gano A, Ofman J. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ 2002, 325:925-932. 10.1136/bmj.325.7370.925, 130055, 12399340.
9. Shojania K, Ranji S, McDonald K, Grimshaw J, Sundaram V, Rushakoff R, Owens D. Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control. A Meta-Regression Analysis. JAMA 2006, 296:427-440. 10.1001/jama.296.4.427, 16868301.
10. Maier M, Knopp A, Pusarnig S, Rurik I, Orozco D, Yaman H, van Eygen L, . European Forum for Diabetes Care Position Paper: Diabetes in Europe: role and contribution of Primary Care. Qual Prim Care 2008, 16:197-207. European Forum for Diabetes Care.
11. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002, 288:2469-2475. 10.1001/jama.288.19.2469, 12435261.
12. Bodenheimer T, Wagner E, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002, 288:1775-1779. 10.1001/jama.288.14.1775, 12365965.
13. Bodenheimer T, Wagner E, Grumbach K. Improving primary care for patients with chronic illness: the Chronic Care Model, Part 2. JAMA 2002, 288:1909-1914. 10.1001/jama.288.15.1909, 12377092.
14. European Medicines Agency ICH Topic E 6 (R1). Guidance On Good Clinical Practice (CPMP/ICH/135/95) European Medicines Agency., http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf
15. IDF Clinical Guidelines Task Force Global guideline for Type 2 diabetes. Brussels: International Diabetes Federation 2005, IDF Clinical Guidelines Task Force.
16. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, . American Heart Association; American Diabetes Association Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007, 30:162-172. 10.2337/dc07-9917, 17192355, American Heart Association; American Diabetes Association.
17. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A, . European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN) European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl 2):E1-E40. European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN).
18. American Diabetes Association Clinical Practice Recommendations. Diabetes Care 2007, 30(Suppl 1):S1-S103. American Diabetes Association.
19. Eccles MP, Whitty PM, Speed C, Steen IN, Vanoli A, Hawthorne GC, Grimshaw JM, Wood LJ, McDowell D. A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial. Implement Sci 2007, 2:6. 10.1186/1748-5908-2-6, 1804280, 17306017.
20. Lachin JM. Biostatistical Methods 2002, New York: John Wiley & Sons.
21. Machin D, Campbell M, Fayers P, Pinol A. Sample Size Tables for Clinical Studies 1997, Oxford: Blackwell Science.
22. Brohet C, De Backer G, Scheen AJ, Van Gaal LF, Duquenne V, Vissers E. Belgian evaluation of screening and treatment of hish-risk patients based on waist and age (Best study). Eur J Cardiac Prev Rehab 2005, 12:280.
23. Kiefe CI, Allison JJ, Williams OD, Person SD, Weaver MT, Weissman NW. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 2001, 285:2871-2879. 10.1001/jama.285.22.2871, 11401608.
24. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393. 10.1056/NEJMoa021778, 12556541.
25. Merlani P, Garnerin P, Diby M, Ferring M, Ricou B. Quality improvement report: Linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care. BMJ 2001, 323:620-624. 10.1136/bmj.323.7313.620, 1121188, 11557715.
26. Scholle SH, Roski J, Adams JL, Dunn DL, Kerr EA, Dugan DP, Jensen RE. Benchmarking physician performance: reliability of individual and composite measures. Am J Manag Care 2008, 14:833-838. 2667340, 19067500.
27. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care 2006, 15:433-436. 10.1136/qshc.2006.018549, 2464905, 17142594.
28. de Grauw WJ, van Gerwen WH, van de Lisdonk EH, van den Hoogen HJ, van den Bosch WJ, van Weel C. Outcomes of audit-enhanced monitoring of patients with type 2 diabetes. J Fam Pract 2002, 51:459-464.
29. Valk GD, Renders CM, Kriegsman DM, Newton KM, Twisk JW, van Eijk JT, van der WG, Wagner EH. Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs. Health Serv Res 2004, 39:709-725. 10.1111/j.1475-6773.2004.00254.x, 1361034, 15230924.
30. Hunt JS, Siemienczuk J, Gillanders W, Leblanc BH, Rozenfeld Y, Bonin K, Pape G. The impact of a physician-directed health information technology system on diabetes outcomes in primary care: a pre- and post-implementation study. Inform Prim Care 2009, 17:165-174.
31. Club Diabete Sicili@ Five-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics. Diabetes Care 2008, 31:57-62. 10.2337/dc08-0284, 17940128, Club Diabete Sicili@.
32. Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ 2009, 338:b1870. 10.1136/bmj.b1870, 2687510, 19474024.
33. Kristensen JK, Lauritzen T. Quality indicators of type 2-diabetes monitoring during 2000-2005. Ugeskr Laeger 2009, 171:130-134.
34. Guldberg T, Lauritzen T, Kristensen J, Vedsted P. The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Family Practice 2009, 10:30. 10.1186/1471-2296-10-30, 2690581, 19419548.
35. Smith SA, Shah ND, Bryant SC, Christianson TJ, Bjornsen SS, Giesler PD, Krause K, Erwin PJ, Montori VM, . Evidens Research Group Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. Mayo Clin Proc 2008, 83:747-757. 10.4065/83.7.747, 18613991, Evidens Research Group.
36. O'Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL. Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial. Diabetes Care 2009, 32:1158-1163. 10.2337/dc08-2247, 2699722, 19366977.
37. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care 2001, 24:1821-1833. 10.2337/diacare.24.10.1821, 11574449.
38. Hysong SJ. Meta-analysis: audit and feedback features impact effectiveness on care quality. Med Care 2009, 47:356-363. 10.1097/MLR.0b013e3181893f6b, 19194332.
39. Debacker N, Nobels F, Vandenberghe H, Van Crombrugge P, Scheen A, Van Casteren V. Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience. Diabet Med 2008, 25:179-185. 10.1111/j.1464-5491.2007.02378.x, 18290859.
40. Debacker N, Van Crombrugge P, Sourdeau L, Libeer J, Van Casteren V, Scheen A, Nobels F. A nationwide external quality assessment programme for HbA1c in Belgium: an example of a quality cycle [abstract]. Diabetic Medicine 2006, 23(Suppl 4):5-199.
41. Final report European Core Indicators in Diabetes project. , http://ec.europa.eu/health/ph_projects/2005/action1/docs/action1_2005_frep_11_en.pdf